Data Foundry

Medical device recalls 2023

ACL ELITE Refurbished-Analyzer designed specifically for clinical use… — Class II medical device recall Z-1306-2023

Ongoing recall by Instrumentation Laboratory, reported 2023-04-05, distributed nationwide. Removes the test definition for HemosIL Liquid Anti-Xa (PN 0020302600 and 0020302601) from the ACL Elite/Elite

Recall numberZ-1306-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmInstrumentation Laboratory, Bedford, MA, United States
Recall initiated2023-02-03
Classified2023-03-30
Reported by FDA2023-04-05
DistributedNationwide (US)
Countries outside the USAT, AU, BE, BG, BR, CA, CH, CN, CO, CZ, DE, DZ, EG, ES, FI, FR, GB, GH, GR, HK, HU, ID, IE, IN, IR, IT, JO, JP, KE, KR, LB, LK, LT, LV, MX, MY, PH, PL, RO, RS, SA, TH, TW, UA, UY, VN, ZA
Quantity1 units
UPC / GTIN / UDI-DI08426950965572
Serial numbers11121320R
Model numbers0000880311R

Product

ACL ELITE Refurbished-Analyzer designed specifically for clinical use in the hemostasis laboratory, for coagulation and/or fibrinolysis testing. Part Number: 0000880311R

Reason for recall

Removes the test definition for HemosIL Liquid Anti-Xa (PN 0020302600 and 0020302601) from the ACL Elite/Elite Pro instruments

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1306-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.